about
Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies.Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infectionsSchistosoma mansonivenom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifsA recombinant subunit vaccine for the control of ovine psoroptic mange (sheep scab).Effectiveness of UNAIDS targets and HIV vaccination across 127 countries.Activated entomopathogenic nematode infective juveniles release lethal venom proteins.Stage and tissue expression patterns of Schistosoma mansoni venom allergen-like proteins SmVAL 4, 13, 16 and 24.Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidateCloning and characterization of a novel sigma-like glutathione S-transferase from the giant panda parasitic nematode, Baylisascaris schroederi.Mucosal immune responses following intestinal nematode infectionThe medical biochemistry of poverty and neglect.Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates.New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74The human hookworm vaccine: recent updates and prospects for success.Molecular Identification of Hookworm Isolates in Humans, Dogs and Soil in a Tribal Area in Tamil Nadu, India.Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseasesCracking the nodule worm code advances knowledge of parasite biology and biotechnology to tackle major diseases of livestock.The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates.Controlling soil-transmitted helminths: time to think inside the box?Vaccination against helminth parasite infections.The Impact of Nurses on Neglected Tropical Disease Management.Update on prevention and treatment of intestinal helminth infections.Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission settingThe role of ILC2 in hookworm infection.Group 2 ILCs: A way of enhancing immune protection against human helminths?Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response.Cloning and expression of a Trichinella spiralis putative glutathione S-transferase and its elicited protective immunity against challenge infectionsA novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development.Lessons from bloodless worms: heme homeostasis in C. elegans.Metazoan Parasite Vaccines: Present Status and Future Prospects.Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development.Silent Witness: Dual-Species Transcriptomics Reveals Epithelial Immunological Quiescence to Helminth Larval Encounter and Fostered Larval Development
P2860
Q26765026-89FCB6F6-93C8-4C71-9E4F-FABC141B8B71Q27023470-BC4111E1-58CF-4CAB-A101-114865ADAD8CQ27684904-036F04EC-743F-4FF0-A884-94C07F4E0A57Q30386012-BE92F661-4E01-4DB3-8399-F5E30FB87961Q30400132-3B0193C3-DB21-4773-9B38-F43D197C5055Q33585400-3FF1FBF3-4D39-4A7B-A44D-ABC809CD42BDQ33651570-9B4122A8-04DD-4F2B-B645-1ECAA1F6C5E7Q34291144-1FB1EE0E-FA75-4D80-9562-ACE367D1952DQ35030184-C1BAA151-0AC6-4473-AD1F-332D4EABD1CEQ35035070-D148796A-BECD-4593-9AC9-33C9857701D0Q35219017-FBBBA4D1-84F3-414A-8EA4-5C9E977CBF2FQ35569944-E3273E48-D658-474A-86F0-ACD6DDD7F77BQ35887080-9B06A746-812E-48FB-9987-7185E8FC0C36Q35936503-71F02E29-C2D6-4C1F-A6BF-E2B055F6C2DFQ36093675-3C5C1135-EF15-41A2-9F67-837022F078D9Q36550981-4B20E287-EACE-4210-8CF0-E3832038D875Q36558899-303AFF31-E190-4547-B44C-B5368E013047Q37291569-5F6E1E90-51A8-4AD9-AE2D-1C8A60D540F6Q38176075-EB793DD4-A731-4990-8335-5F3EC90E1A84Q38194247-11A54519-1C03-4549-8B6C-33F5710E3F41Q38250382-AAAA3D5F-F986-4157-B7F0-A216FB01499CQ38395403-9C0C5B40-B331-423D-8825-21EE98B6F9A3Q38895404-DE6A3636-4AC1-4324-9872-ECA9B2594043Q39215742-4386E5AF-0D40-4D39-AD0C-16D28FA52659Q39381981-1B946446-BF7C-41FF-8FD7-930F2793A622Q39584080-20F1350B-E7AE-4850-896C-C2F7EA064B46Q42368049-1FC067F7-71C5-41AF-B4EE-D525601A1F0BQ51730343-66CFAAE4-1A99-4065-ABC9-734EFB4E5173Q53232578-519495D2-7399-42C3-931B-6147E4BC0620Q55024731-6173992D-957B-45A7-8B1C-2CEEDBEADCACQ55324839-65D0D3EE-9D85-4ED8-A808-3E459046A4E9Q58777566-AEDEF23E-2F38-49E8-9DBF-01DFA529985A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Human Hookworm Vaccine.
@en
The Human Hookworm Vaccine.
@nl
type
label
The Human Hookworm Vaccine.
@en
The Human Hookworm Vaccine.
@nl
prefLabel
The Human Hookworm Vaccine.
@en
The Human Hookworm Vaccine.
@nl
P2093
P2860
P50
P1433
P1476
The Human Hookworm Vaccine.
@en
P2093
Akira Homma
Artur Roberto Couto
Carlos Medicis Morel
Coreen Beaumier
Jeffrey M Bethony
Kristina M Bacon
Marcos da Silva Freire
Marva Loblack
Philip K Russell
Rodrigo Correa Oliveira
P2860
P304
P356
10.1016/J.VACCINE.2012.11.034
P407
P478
31 Suppl 2
P5008
P577
2013-04-01T00:00:00Z
2013-04-18T00:00:00Z